Drugs · acquisition-cost intelligence
methylprednisolone
· ingredient methylprednisoloneCorticosteroids, combinations for treatment of acne· METHYLPREDNISOLONE 16 mg/1; METHYLPREDNISOLONE 32 mg/1; METHYLPREDNISOLONE 4 mg/1; METHYLPREDNISOLONE 8 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$1.03
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other methylprednisolone products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| methylprednisolone | $0.12425 | −$0.90810 |
| Medrol | $0.25840 | −$0.77390 |
| Methylprednisolone Sodium Succinate | $4.06 | +$3.03 |
| DEPO-MEDROL | $5.81 | +$4.78 |
| Solu-Medrol | $6.27 | +$5.24 |
| Depo-Medrol | $10.97 | +$9.94 |
| Depo-Medrol | $11.96 | +$10.93 |
Medicare Part D coverage · CY2026
On 328 plan formularies · typical tier 2
Prior auth 42% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.